Search

Author/Creator Andrews, Miles C

1. Characterization of the treatment-naive immune microenvironment in melanoma with BRAF mutation. Issue 4 (5th April 2022)

Authors:
Wang, Minyu; Zadeh, Soroor; Pizzolla, Angela; Thia, Kevin; Gyorki, David E; McArthur, Grant A; Scolyer, Richard A; Long, Georgina; Wilmott, James S; Andrews, Miles C; Au-Yeung, George; Weppler, Ali; Sandhu, Shahneen; Trapani, Joseph A; Davis, Melissa J; Neeson, Paul Joseph
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 4(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial. Issue 2 (February 2018)

Authors:
Amaria, Rodabe N; Prieto, Peter A; Tetzlaff, Michael T; Reuben, Alexandre; Andrews, Miles C; Ross, Merrick I; Glitza, Isabella C; Cormier, Janice; Hwu, Wen-Jen; Tawbi, Hussein A; Patel, Sapna P; Lee, Jeffrey E; Gershenwald, Jeffrey E; Spencer, Christine N; Gopalakrishnan, Vancheswaran; Bassett, R...
Journal:
Lancet oncology
Issue:
Volume 19:Issue 2(2018)
Page Start:
181
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium. Issue 7 (July 2019)

Authors:
Andrews, Miles C; Berry, Donald A; Block, Matthew S; Boland, Genevieve M; Bollin, Kathryn B; Carlino, Matteo S; Carvajal, Richard D; Cohen, Jonathan; Davar, Diwakar; Delman, Keith A; Dummer, Reinhard; Farwell, Michael D; Fisher, David E; Fusi, Alberto; Glitza, Isabella C; de Gruijl, Tanja D; Gyor...
Journal:
Lancet oncology
Issue:
Volume 20:Issue 7(2019)
Page Start:
e378
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure. Issue 8 (12th June 2017)

Authors:
Smith, Michael P; Rowling, Emily J; Miskolczi, Zsofia; Ferguson, Jennifer; Spoerri, Loredana; Haass, Nikolas K; Sloss, Olivia; McEntegart, Sophie; Arozarena, Imanol; von Kriegsheim, Alex; Rodriguez, Javier; Brunton, Holly; Kmarashev, Jivko; Levesque, Mitchell P; Dummer, Reinhard; Frederick, Denni...
Journal:
EMBO molecular medicine
Issue:
Volume 9:Issue 8(2017)
Page Start:
1011
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗